Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature currently requires accessing the site using the built-in Safari browser.
You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
Mon news: AZ obesity pill. 50% of drug shortages last at least 2 years. Pharmas and IRA lawsuit appeals. Novo-Ascendis biobucks deal. Wegovy reduces all-cause hospital admissions. See more on our front page
In the past two weeks, Celgene has reported positive results from 3 clinical trials. This includes two studies with its partner Acceleron. https://news.alphastreet.com/celgene-gets-a-booster-shot-from-recent-positive-clinical-trial-results/
Celgene announces positive results from the trials with its development partners Bluebird Bio and Juno Therapeutics in ASH 2017.
I think it's an advantage for all the three companies involved; especially for Bluebird Bio.
anonymous
Thread
american society of hematology
bluebird bio
cancer
cancer treatment
celgene
juno therapeutics
lymphoma
myeloma
partnership
Approximately 30 million Americans have diabetes, and nearly 24 percent of Americans with diabetes are undiagnosed. This partnership will create a model that predicts complications from type 2 diabetes